Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 1 trial registration with no reported results; it is designed to evaluate safety, tolerability, and proof of mechanism in a small population, and cannot yet inform clinical practice.
This is a planned observational registry study with no results yet reported; it will characterize safety and disease progression in routine clinical practice but cannot yet inform clinical decisions.
FDA supplemental approval of lecanemab autoinjector formulation; regulatory action record that does not contain clinical trial efficacy or safety data.